Kathryn E. Wengel - 11 Feb 2026 Form 4 Insider Report for LABCORP HOLDINGS INC. (LH)

Role
Director
Signature
/s/ Kathryn W. Kyle, Attorney-in-Fact for Kathryn E. Wengel
Issuer symbol
LH
Transactions as of
11 Feb 2026
Net transactions value
$0
Form type
4
Filing time
13 Feb 2026, 12:58:47 UTC
Previous filing
12 Feb 2026
Next filing
18 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wengel Kathryn E Director 531 SOUTH SPRING STREET, BURLINGTON /s/ Kathryn W. Kyle, Attorney-in-Fact for Kathryn E. Wengel 13 Feb 2026 0001745955

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LH Common Stock Options Exercise +897 +28% 4,133 11 Feb 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Restricted Stock Unit Options Exercise $0 -897 -54% $0.000000 773 11 Feb 2026 Common Stock 897 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
F2 The Restricted Stock Units vested fully on February 11, 2026.
F3 This number reflects the aggregate number of Restricted Stock Units held by the reporting person.